In the respective endometrial carcinoma TCGA PanCancer Atlas study, which included 509 cases with complete mutations and copy number alterations information [23], among the 27 cases with CTCFL mutations 22 had mutations in one of the four MSI associated genes or the POLE or POLD1 genes. This evidence concerns the gene POLE and endometrial carcinoma.